Treatment type: Immunotherapies

  • RNA boost for autoimmune disease

    The enormous potential of RNA-based treatments for autoimmune diseases has been recognised by the Victorian government, with a new grant from the mRNA Victoria Research Acceleration Fund.…  Read more

    Associate Professor Michael Gantier has been awarded a new grant to research further into RNA-based treatments for autoimmune diseases.

  • Flicking the inflammation off-switch

    Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
    There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.…  Read more

    A/Prof Claudia Nold and Professor Marcel Nold from The Ritchie Centre at Hudson Institute of Medical Research

  • Lachy’s story: hope against Stage IV neuroblastoma

    At 18 months, Lachy developed fevers, vomiting and general tiredness. Doctors thought it was a daycare virus and he would get over it. Lachy had an 11 cm tumour in his abdomen and was diagnosed with Stage IV neuroblastoma, which had spread to his bone marrow.…  Read more

    Isabella and Lachy having cuddles whilst having treatment in hospital

  • Silicosis research awarded more than $1.6 million

    Hudson Institute of Medical Research and Monash University have received more than $1.6 million in funding from the Federal Government’s Medical Research Future Fund (MRFF) towards research investigating ways to prevent and treat silicosis.…  Read more

    Inflammation scientists Associate Professor Michelle Tate and Associate Professor Ashley Mansell

  • Ovarian cancer treatment hope

    Hudson Institute researchers have shown for the first time that a diabetes drug called sitagliptin can limit tumour growth, and possibly extend survival rates from epithelial ovarian cancer, the most common and dangerous type of ovarian cancer.…  Read more

    Scientist, Dr Amy Wilson at Hudson Institute

  • NHMRC Ideas Grants success

    Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million.…  Read more

    Sam, Paul, Ed and Vince, Hudson Institute's successful NHMRC Ideas Grants recipients

  • ARC Discovery Projects success

    Hudson Institute researchers have been awarded more than $2 million from the Australian Research Council Discovery Projects Grant round.…  Read more

    Prof Richard Ferrero, A/prof Patrick Western, Dr Nicole de Weerd and Dr Sam Forster, successful ARC Discovery Projects 2020

  • Motor neuron disease inflammation trigger discovered

    In collaboration with colleagues at the Walter and Eliza Hall Institute (WEHI) and the University of Melbourne, Hudson Institute scientists have revealed how inflammation in motor neuron disease (MND) is caused,…  Read more

    Dr Michael Gantier from the Nucleic Acids and Innate Immunity Research Group at Hudson Institute

  • US President Donald Trump has COVID-19 and is on a cocktail of experimental drugs. What does this mean for his health?

    It is unknown how US President Donald Trump will respond to the experimental immunotherapy given to treat his COVID-19 infection, because the drug has not yet been tested and approved, says Hudson Institute Director and CEO, Professor Elizabeth Hartland.…  Read more

    Professor Elizabeth Hartland, director, CEO, Hudson Institute of Medical Research

  • Key to immune system inflammation discovery

    Hudson Institute scientists have discovered the key to how cells turn on inflammation and fight infection, providing the knowledge to potentially reduce or stop destructive inflammation in the future.…  Read more

    Associate Professor Ashley Mansell and Dr Dan Gough at Hudson Intitute